Format

Send to

Choose Destination
J Wound Care. 2008 Sep;17(9):380-2.

Management of a hypertensive ulcer with an epidermal growth factor-based formulation.

Author information

1
canete@trocha.cav.sld.cu

Abstract

This rare ulcer was treated with a human recombinant epidermal growth factor-based formulation and antihypertensive drugs. Full granulation was achieved in 49 days and complete wound closure in 79 days. No adverse events were reported.

PMID:
18833895
DOI:
10.12968/jowc.2008.17.9.30935
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center